Delivery Order SPE2DB24D2205-SPE2DB25FEFDG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $26,811.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $30,943.32 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on September 11, 2025, with completion expected by September 12, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $17,544.13 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This is a firm fixed price contract with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 15 mg/0.5 mL pens with a ceiling value of $8,811.53. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This...
- The Defense Logistics Agency awarded a $3,050.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. The order is scheduled for completion by September 2, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a $16,914.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which...
- The Defense Logistics Agency awarded a delivery order valued at $11,831.93 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery order fulfillment for pharmaceutical supplies to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's Corporate Office...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFDGDelivery Order
The Defense Logistics Agency awarded a $48,739.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award for a single-unit delivery order. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle, enabling the supply of brand-name and generic drugs, specialty medications, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. As a child delivery order under this prime contract vehicle, the Zepbound order represents one of numerous pharmaceutical deliveries the contractor fulfills through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.7k | 7/21/25 |